AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DICLOFENAC DE SODIUM
14 registrations across 1 African market— 14 active
Markets with DICLOFENAC DE SODIUM
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| WARI-DICLOWAL ampoule injectable / 75 mg / 3 ml | 🇸🇳Senegal | WALTER RITTER PHARMACEUTICA /GMBH | active | — |
| OLFEN-100 RETARD gélule à libération prolongée / 100 mg | 🇸🇳Senegal | MEPHA PHARMA | active | — |
| OLFEN comprimé / 100 mg | 🇸🇳Senegal | MEPHA PHARMA | active | — |
| OLFEN suppositoire / 50 mg | 🇸🇳Senegal | MEPHA PHARMA | active | — |
| OLFEN-50 comprimé gastro-resistant / 50 mg | 🇸🇳Senegal | MEPHA PHARMA | active | — |
| OLFEN comprimé / 25 mg | 🇸🇳Senegal | MEPHA PHARMA | active | — |
| DOLEX SR comprimé / 75 mg | 🇸🇳Senegal | LIKATA PHARMACEUTICAL LTD | active | — |
| NEURODOL solution injectable / 75 mg / ml | 🇸🇳Senegal | AHAAN HEALTHCARE PVT LTD | active | — |
| DOLEX solution injectable / 75 mg/ml | 🇸🇳Senegal | GENERIC HEALTH CARE PVT. LTD | active | — |
| DYNAPAR SR comprimé / 100 mg | 🇸🇳Senegal | TROIKAA PHARMACEUTICALS LIMITED | active | — |
| GROFENAC RETARD comprimé / 100 mg | 🇸🇳Senegal | DR GROSSMAN | active | — |
| OLFEN gel / 1 % | 🇸🇳Senegal | MEPHA PHARMA | active | — |
| DICLOFENAC UBITHERA ampoule injectable / 75 mg / 3ml | 🇸🇳Senegal | UBITHERA PHARMA PVT LTD | active | — |
| DOLEX solution injectable / 75 mg/ml | 🇸🇳Senegal | GENERIC HEALTH CARE PVT. LTD | active | — |
DICLOFENAC DE SODIUM in Africa — Regulatory Overview
DICLOFENAC DE SODIUM is registered across 1 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 14 registrations, 14 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.